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The muscle-speciﬁc RING ﬁnger proteins MuRF1 and
MuRF2 have been proposed to regulate protein degrada-
tion and gene expression in muscle tissues. We have tested
the in vivo roles of MuRF1 and MuRF2 for muscle meta-
bolism by using knockout (KO) mouse models. Single
MuRF1 and MuRF2 KO mice are healthy and have normal
muscles. Double knockout (dKO) mice obtained by the
inactivation of all four MuRF1 and MuRF2 alleles devel-
oped extreme cardiac and milder skeletal muscle hyper-
trophy. Muscle hypertrophy in dKO mice was maintained
throughout the murine life span and was associated with
chronically activated muscle protein synthesis. During
ageing (months 4–18), skeletal muscle mass remained
stable, whereas body fat content did not increase in dKO
mice as compared with wild-type controls. Other catabolic
factors such as MAFbox/atrogin1 were expressed at
normal levels and did not respond to or prevent muscle
hypertrophy in dKO mice. Thus, combined inhibition of
MuRF1/MuRF2 could provide a potent strategy to stimu-
late striated muscles anabolically and to protect muscles
from sarcopenia during ageing.
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Introduction
Striated muscle cells respond to changing functional require-
ments by a coordinated set of adaptations. For example,
resistance training effectively remodels myoﬁbrils, ﬁber
type compositions, mitochondrial content, and muscle cell
sizes (Seynnes et al, 2007), leading to body and skeletal
muscle mass increases of 2–5kg and strength gains of
5–20% within one week in athletes after optimal exercise
and nutrition (for review, see Hartgens and Kuipers, 2004).
Conversely, acute muscle unloading or starvation induces
muscle protein catabolism (about 0.3% of calf muscle mass is
lost per day in bed-rested patients (Rittweger et al, 2005), and
up to 35% muscle loss in rats after 1 week of space ﬂight
(Fitts et al, 2001)). The trophic pathways promoting muscle
growth and protein synthesis are modulated by a plethora
of factors, including hormones, exercise, and myocellular
stretch (for review, see Bassel-Duby and Olson, 2006), that
enhance muscle tissue and myocytic cell growth. In vivo,
these must be balanced by anti-anabolic signals that are less
understood. Pathophysiologically, dominance of catabolism
causes muscle wasting syndromes, for example, critical ill-
ness myopathies (Latronico et al, 2005), or blunted anabo-
lism causes sarcopenia during ageing (Solomon and Bouloux,
2006). Because of their clinical importance, muscle catabo-
lism-promoting factors are receiving increasing attention (for
review, see Bodine, 2006), in particular, the ubiquitin ligases
MAFbx/atrogin1 and MuRF1, because of their consistent
upregulation during a variety of catabolic muscle states,
including denervation, long-term immobilization, and micro-
gravity (Lecker et al, 2004; Nikawa et al, 2004). Consistent
with a critical role of MAFbx/atrogin1 and MURF1 for muscle
catabolism, MAFbx/atrogin1 and MuRF1 knockout (KO)
mice develop muscle atrophy more slowly after denervation
(Bodine et al, 2001).
The shared binding of MuRF1 and MuRF2 to a set of seven
structural muscle proteins (including titin; see Witt et al,
2005) prompted us to investigate the functional relationship
between MuRF1 and MuRF2 by mouse genetics. For example,
titin may regulate the E3-ligase activities of MuRF1 and
MuRF2 in an activity-dependent fashion: titin is a giant
intrasarcomeric protein that makes up a myoﬁbrillar span-
ning system, confers elastic properties to the myoﬁbrils, and
associates with numerous signaling molecules whose expres-
sion is muscle-activity dependent (for review, see Miller et al,
2003; Granzier and Labeit, 2004; Lange et al, 2005; Peng et al,
2005). Thus we generated MuRF1 and MuRF2 KO mouse
models for testing whether MuRF1 and MuRF2 functionally
cooperate. Both MuRF1 and MuRF2 KO mice have normal
fertility and life span (consistent with Bodine et al, 2001;
Willis et al, 2007). In contrast, MuRF1/MuRF2 double knockout
(dKO) mice develop an extreme and lifelong muscle hypertro-
p h y .T h em o l e c u l a rb a s i sf o rt h ec o o p e r a t i v en a t u r eo fM u R F 1 / 2
signaling is likely their combined regulation of a large shared
set of ligands, including proteins required for myoﬁbrillar
stretch sensing, translation, and transcription factors.
Cooperative MuRF1/2 signaling is emerging as an important
pathway that coordinates myoﬁbrils, ribosomes, and nuclear
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350gene expression in myocytes when being stressed metaboli-
cally or biomechanically.
Results
Increase of heart organ and cardiac myocyte size after
deletion of MuRF1 and MuRF2
Our MuRF1 and MuRF2 KO mouse models correspond both
to constitutive null models (for details on gene targeting, see
Supplementary Figure 1B–D). The obtained MuRF1 and
MuRF2 KO mice that are homozygous null for MuRF1 or
MuRF2 have normal fertility and are viable (consistent with
Bodine et al, 2001; Willis et al, 2007). Also, deletion of
MuRF1 or MuRF2 has no effect on life span until month 24
(our oldest MuRF1 or MuRF2 KO mice so far). Fertility
of single MuRF1 or MuRF2 KO mice allowed the generation
of dKO strains by breeding them together. Newborn dKO mice
have a severe phenotype: 74% of mice homozygous for both
MuRF1 and MuRF2 KO alleles die within the ﬁrst 7–16 days
of life. Dissection of these young dKO mice revealed
grossly enlarged hearts that ﬁlled the entire mediastinum
(Figure 1A and B).
Histology of mice that died spontaneously revealed micro-
thrombi in the heart, edema in the lung, microbleedings, and
compression of the neighboring organs (Supplementary
Figure 2). Taken together, these pathological ﬁndings are
consistent with death from chronic heart insufﬁciency and
acute cardiac decompensation with heart failure.
Morphometric analysis of single cardiac myocytes demon-
strated 59% enlarged myocytes and 58% enlarged nuclei,
both indicating cellular hypertrophy and explaining muscle
hypertrophy at least in part (see Figure 1C). The effects of
deleting MuRF1 and MuRF2 alleles on heart to body weight
(HW/BW) ratios were synergistic: young MuRF1 or MuRF2
KO mice had 10 and 8% HW/BW increases (P¼0.1 and
0.2 respectively), whereas hearts of dKO mice had 231%
increased HW/BW ratios (P¼0.001, o1 month; Figure 1B
right). The histological studies of older mice revealed for dKO
myocardium a concentric-type hypertrophy. No ﬁbrosis by
Masson stainings or myoﬁbrillar disarray was observed at
light microscopic level (Figure 1D bottom). The inner and
outer layers of the myocardium could still be distinguished
(Figure 1D).
Taken together, the severe phenotype of dKO mice
contrasts the absence of a noticeable phenotype in MuRF1
or MuRF2 KO mice and therefore demonstrates cooperativity
of MuRF1 and MuRF2 on the genetic level.
dKO mice develop and maintain skeletal and cardiac
muscle hypertrophy throughout their life span
Those dKO mice that survived the ﬁrst two postnatal weeks
became long-term survivors: All dKO mice alive at week 3
(n¼27; 26% of total dKO offspring) were still alive at month
18 (unless being killed for our studies) and were able to
have offspring. Adult dKO mice maintain cardiac hyper-
trophy (dKO: 84% increase, P¼0.001; see Figure 2B). Con-
sistent with this, electrocardiography indicated intact
excitation conduction in dKO hearts from aged mice
(see Supplementary Figure 3; contrasting, for example, the
conduction blocks observed in Nkx2.5 KO mice; see
Pashmforoush et al, 2004). Next, we examined the physio-
logical cardiac performance by MRI imaging in more detail.
This indicated massive persistent hypertrophy (see
Figure 2A). Next, we estimated ejection fractions (EF) and
stroke volumes by time-resolved MRI. This showed grossly
reduced EFs (dKO: 0.2–0.3; wild type (WT): 0.7; see
Figure 2A), whereas stroke volumes were 26% reduced
under basal conditions.
Because dKO hearts support physiological circulation at
least under non-challenged laboratory conditions for up to
month 18, the effects of the absence of both MuRF1 and
MuRF2 could also be studied in muscles of adult and aged
animals. Similar to sustaining cardiac hypertrophy up to
month 18 (our oldest dKO mice), MuRF1 and MuRF2 had
also synergistic lifelong effects on skeletal muscle mass:
after deletion of all four alleles, we found 38% increased
quadriceps to body weight (QW/BW) ratios in dKO mice
when compared with WT (P¼0.001), whereas single
MuRF1 or MuRF2 KOs had 17 and 11% increased QW/BW
ratios (P¼0.05 and 0.08, respectively; Figure 2B left). Similar
as in heart muscle, skeletal muscle hypertrophy correlated
with the hypertrophy of individual ﬁbers (see histology of
quadriceps muscle; Figure 2B right).
Intriguingly, during ageing, body weights of dKO and
WT mice progressively diverged: whereas ageing WT mice
substantially gained weight (64% increase when comparing
months 5 and 18), weight gains were attenuated in dKO
mice (17, 27, and 35% differences at 12, 15, and 18 months,
respectively (P¼0.001), Figure 2C left). Dissections of
senescent WT and dKO mice indicated that a striking lack
of body fat accumulation in senescent dKO mice accounted
for their reduced weights (Figure 2C right). This was
apparently not linked to a general cachexia, because skeletal
muscle hypertrophy was maintained (Supplementary
Figure 8 right).
Identiﬁcation of binding partners shared by MuRF1 and
MuRF2 and their convergent signaling on CARP, FHL2,
and SQSTM1
Because muscle hypertrophy and the lean phenotype develop
only after inactivation of all four MuRF1 and MuRF2 alleles,
we searched for binding partners that are recognized by both
MuRF1 and MuRF2 in an attempt to ﬁnd molecular explana-
tions for the phenotypic synergistic effects of MuRF1 and
MuRF2 on muscle protein and lipid/energy metabolism.
A total of 87 genes were identiﬁed as MuRF1 or MuRF2
interacting prey clones that coded for myoﬁbrillar proteins
(18, including 11 Z-disk proteins), transcriptional regulators
(11), translation factors (4), and component of the mito-
chondrial proteome (including ATP-synthesis (9)). Of these
87 genes, a set of 35 genes was ﬁshed with both MuRF1 and
MuRF2 baits and was further conﬁrmed by mating studies.
The group of ligands shared by MuRF1 and MuRF2 included a
set of four myoﬁbrillar Z-disk proteins and the transcriptional
regulators CARP, myozenin1/calsarcin2, FHL2 (also asso-
ciated with Z-disk region; for review, see Clark et al, 2002)
(Figure 3A). To further test whether the Yeast Two-Hybrid
(YTH) prey clones code indeed for MuRF1 and MuRF2
binding proteins, we performed in vitro pull-down studies
using expressed CARP, myozenin1/calsarcin2 (two molecules
selected as known transcriptional regulators of muscle gene
expression), MRP-L41/pig3 (selected as a member of the
mitochondrial ribosomal group, also being implicated in
growth control; see Yoo et al, 2005), and EEF1G/EF-1g
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&2008 European Molecular Biology Organization The EMBO Journal VOL 27 | NO 2 | 2008 351Figure 1 Synergistic control of heart muscle mass and cardiac myocyte size by MuRF1 and MuRF2. (A) Dissection of 13-day-old MuRF1 and
MuRF2-dKO mice revealed grossly enlarged hearts (h), causing caudally lung compression (lu); the liver appears hyperaemic (li). (B) Effect of
MuRF1/MuRF2 genotypes on heart weights. Left: hearts isolated from two matched pairs of WTand dKO mice (13 days old). Right: dKO mouse
hearts (ventricles only) had 231% (P¼0.001) increased HW/BW ratios, whereas weights of MuRF1, MuRF2 KO, and WT hearts did not differ
signiﬁcantly (young mice between d8 and d24; MuRF1: 25.5% increase, P¼0.1, MuRF2: 27%, P¼0.2, heart ventricles weights, respectively;
dKO n¼18; MuRF1 KO n¼6, MuRF2 KO n¼7; WT n¼7). (C) Left: hematoxylin/eosin (HE) sections indicated that cardiomyocytes from
young dKO hearts were hypertrophic. Scale bar, 20mm. Right: morphometric comparison of WTand dKO sections nuclei had 59% increased
length and cardiomyocytes were also 58% larger/cell density was reduced by 58% (as indicated by the number of cells in 0.2mm
2 large
sections). (D) HE (top) and Masson histology (bottom) of WTand dKO hearts indicated concentric-type physiological hypertrophy at month 12,
with intact inner and outer circular ﬁber systems and absence of ﬁbrosis. Scale bar, 1mm.
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lation machinery; see Belle et al, 1995) as well as its mitochon-
drial counterpart GFM1. Results indicated that a central MuRF1
fragment that comprises the MuRF1 residues 109–315
(‘MuRF1Bcc’; see Supplementary Figure 1A) is both sufﬁcient
and required for interaction with CARP, EEF1G, GFM1, myoze-
nin1/calsarcin-2, and pig3/MRP-L41 (Figure 3B). Similarly,
expressed MuRF2Bcc interacted in vitro with CARP, EEF1G,
and GFM1 (Figure 3B). Finally, YTH mating suggested that
MuRF3Bcc does not interact with CARP, myozenin-1/calsar-
cin-2, and pig3/MRP-L41 (data not shown).
MuRF3 was recently shown to interact also with FHL2 and
suggested to regulate its expression as an E3-ubiquitin ligase
(Fielitz et al, 2007). Therefore, we tested next whether the
expression of MuRF3 and FHL2 are affected in dKO mice.
MuRF3 was expressed at normal levels in dKO mice (Array
Express E-MEXP-1321), whereas the FHL2 protein was highly
upregulated in dKO mice deﬁcient for both MuRF1 and
MuRF2 (Figure 5A). Thus MuRF1/2 signaling on FHL2
is cooperative and cannot be substituted by the related
ubiquitin ligase MuRF3. Intriguingly, other catabolic factors,
such as atrogin1, are expressed at normal levels in dKO
myocardium (see Supplementary Table 9), suggesting that
MuRF1/MuRF2 and atrogins are functioning in different
pathways. In contrast, CARP and SQSTM1 (Sequestosome1/
p62) became strongly upregulated only after inactivation of
Figure 2 Phenotype of dKO mice at 18 months of age. Perinatally, dKO mice have a high mortality of 74%. The 26% of dKO mice (n¼27) that
survived became long-term survivors and were all alive at month 18 (unless killed, see below), thus allowing phenotypic studies in aged dKO.
(A) MRI scans detected hypertrophic hearts in adult dKO mice with reduced EFs and stroke volumes (for time-resolved MRI scans, see also
Supplementary Videos 4–7). LV, left ventricle; RV, right ventricle; EDV, end-diastolic volume; ESV, end-systolic volume (total number of mice
scanned: two mice of each genotype. (B) Left: effect of MuRF1/2 genotypes on heart (ventricles, left) and quadriceps skeletal muscle (right) to
body weight ratios. dKO mice maintain cardiac hypertrophy during ageing (dKO, 84% increase, P¼0.001; MuRF1, 24.5% increase; MuRF2,
19%). In addition, dKO mice have 38.1% increased QW/BW ratios (P¼0.001), whereas MuRF1 KO and MuRF2 KO genotypes have moderate
effects on skeletal muscle mass (MuRF1, 16% increase, P¼0.05; MuRF2, 11% increase, P¼0.08). Despite increasing body mass in WT during
months 4–18, skeletal muscles remain more hypertrophic in dKO mice during ageing (4–18 months of age, dKO n¼27; MuRF1 KO n¼52;
MuRF2 KO n¼81; WT n¼49). For absolute weights, please refer to Supplementary Figure 8. Right: hematoxylin/eosin sections indicated that
skeletal myoﬁbers from dKO muscle show hypertrophic ﬁbers with slightly augmented cross-section areas alternating with normal-appearing
ﬁbers (mice aged 4 months). Scale bar, 100mm. (C) Weight gain of WTand dKO mice during ageing. Left: between months 4–18, dKO mice gain
less weight (red; Po0.001) than WT. Right: dissections revealed that aged dKO mice were leaner (mice aged 18 months).
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&2008 European Molecular Biology Organization The EMBO Journal VOL 27 | NO 2 | 2008 353Figure 3 MuRF1 and MuRF2 interact with a shared set of myocellular proteins. (A) YTH screens with full-length MuRF1 and MuRF2 baits of
both human cardiac (‘heart’) and skeletal cDNA libraries (‘SKM’) ﬁshed a total of 87 genes. The table summarizes those 35 prey clones
identiﬁed independently in both MuRF1 and MuRF2 screens and thus predicted to interact with both MuRF1þ2: 13 prey clone inserts code for
sarcomeric proteins (4 of which are components of the Z-disk), 10 code for transcriptional regulators (2 of which are also associated with the Z-
disk), 5 genes are involved in mitochondrial ATP production, and 6 genes participate in translation initiation and elongation. Numbers indicate
independently identiﬁed prey clones in respective screens. M¼interaction was found by mating. An SRF prey clone ﬁshed with the MuRF1 bait
could not be conﬁrmed by mating, as in our hands the 30 UTR and not the coding sequence of SRF activated yeast growth during mating with
MuRF1 and 2. (B) The interaction of selected proteins derived from the above-mentioned genes was studied in vitro by pull-downs using
expressed MuRF1/MuRF2 Bcc (B-Boxþcoiled-coil domain) and MuRF1cc (coiled-coil domain) constructs (see also Supplementary Figure S1
and methods). MuRF1cc and MuRF1Bcc (arrows) co-eluted together with CARP, EEF1G, GFM1 MBP fusion proteins. Below: left—MuRF1cc
co-eluted with myozenin-1/calsarcin-2, and MRP-L41/Pig3 MBP-fusion proteins; right—MuRF2Bcc co-eluted together with CARP, EEFG1,
GFM1 MBP fusion proteins; controls—MBP plus MuRF1cc, Bcc, MuRF2Bcc, respectively, or fusion proteins only.
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sion proﬁling with Affymetrix system indicated that FHL2
and SQSTM1 mRNA levels are normal in dKO myocardium,
and CARP is moderately upregulated (Supplementary Table
9). Therefore, upregulation of CARP, FHL2, and SQSTM1
in dKO hearts are primarily caused by post-transcriptional
mechanisms.
Impaired mitochondrial ultrastructure and alteration
of Z-disks after deletion of MuRF1 and MuRF2
Because MuRF1 and MuRF2 interact with multiple compo-
nents of the Z-disk and of the mitochondrium (Figure 3A), we
studied the ultrastructural effects of the absence of MuRF1
and MuRF2 on Z-disks and mitochondria in myocardium by
electron microscopy. We were unable to detect differences
between WT, MuRF1, and MuRF2-KO myocardium (Figure
4A and B). In contrast, myoﬁbrils in dKO myocardium were
abnormal: myoﬁbrils had more electron-dense Z-disks and
were less regular (Figure 4C and D). Occasionally, myoﬁbrils
assembled in dKO hearts had free ends, somewhat reminis-
cent of growth tips found in proliferating skeletal myotubes
(Ojima et al, 1999), and projected into regions rich in
unassembled free ﬁlaments (not shown).
Mitochondria were less regular in shape and less orderly
packed together. dKO myocardium also contained vacuoles,
often embedded into mitochondrial clusters (Figure 4C and
D). Because of the mitochondrial defects, we tested the
expression of PGC-1-a (as a master gene for mitochondrial
biogenesis; see Rasbach and Schnellmann, 2007). PGC-1-a
transcription was not dysregulated in dKO myocardium
(see Supplementary Table S9). Future studies are required
to determine the molecular basis of altered mitochondrial
numbers and structures in dKO myocardium.
These ultrastructural changes were only present after
inactivation of all four MuRF1 and MuRF2 alleles,
again demonstrating that the MuRF1 and MuRF2 loci are
genetically a complementation group.
Elevated ANP and MLP stretch signals in dKO muscles
implicate MuRF1/MuRF2 in stretch signal inhibition
To gain insights into the mechanisms causing cardiac hyper-
trophy in dKO mice, we analyzed their transcriptomes by
gene expression proﬁling. The transcriptional changes we
found in dKO ventricles resembled those present in pressure
induced aortic constriction (Zhao et al, 2004), including the
upregulation of skeletal-type alpha actin 1, myosin light
chains, atrial natriuretic peptide (ANP; isoforms A and B),
and thrombospondin (see Supplementary Figure 9 and
ArrayExpress accession E-MEXP-1321). Consistent with ele-
vated stretch signaling, ANP was strikingly upregulated in
dKO ventricles (Figure 5B). Normal to moderately elevated
expression of other markers for cardiac hypertrophy
suggested that the ANP induction was not a secondary
consequence of heart failure and calcium overload
(Figure 5A). SERCA2a (a marker for calcium overload during
heart failure), serum response factor (SRF, previously
suggested to transmit titin kinase/MuRF2-dependent stretch
signals; Lange et al, 2005), and p38 MAPK (activated by the
ERK/Map kinase pathway) were not affected by the
absence of MuRF1 or MuRF2. In dKO myocardium, neither
microarrays nor western blots showed an upregulation of SRF
(Figure 5B and Supplementary Table 9).
Based on the elevated ANP levels in dKO ventricles, we
hypothesized that stretch signaling is augmented in dKO
muscles because of the failure to attenuate it. To test
Figure 4 Altered Z-disks and mitochondrial ultrastructure in dKO myocardium. (A, B) At 18 months, we noted no ultrastructural abnormalities
in myocardium from WT (A), MuRF1-KO (B), and MuRF2 KO (not shown) mice. (C, D) In dKO myocardium, sarcomere lengths and myoﬁber
alignments are less regular (maximal variation is 2.5-fold larger than in WTsarcomeres). Z-disks have a denser appearance (arrows). Vacuoles
(V) are frequently found between or embedded within mitochondria (M). Mitochondria are less regular in shape including abnormally small
mitochondria and are, unlike in WT, not tightly packed together. Scale bar, 1mm.
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skeletal muscles by a bycast. MLP/Csrp3 is required for
stretch-regulated responses in myocardium and a binding
partner of the Z-disk-associated protein TCap (Knoell et al,
2002) and is also expressed in skeletal muscle (in contrast to
ANP). Therefore, we monitored MLP/Csrp3 as a marker
protein for stretch signaling. MLP/Csrp3, already elevated
at basal conditions, remained highly elevated after a 72h
bycast immobilization in dKO (see Figure 5C). Taken to-
gether, our data demonstrate that combined inactivation of
MuRF1 and MuRF2 leads to chronic upregulation of stretch
signals in both heart and skeletal muscle and failure to
downregulate them.
Synergistic control of translational regulatory
components by MuRF1/2
Possibly, the massive hypertrophic phenotype of dKO mice
might be caused by reduced multi-ubiquitination and
degradation of total muscle proteins (linked to inactivation
of MuRF1/2 E3-ubiquitin-ligase activities). To test for reduced
ubiquitination/degradation, we determined the levels of
multi-ubiquitinated proteins on western blot panels display-
ing the different MuRF1/2 genotypes. Total levels of
multi-ubiquitinated proteins did not change upon MuRF1/2
inactivation (Figure 5A). Among the family of ubiquitin-
related modiﬁers, we only noted for SUMO4 an upregulation
of SUMO4ylated species after MuRF1/2 inactivation
(Figure 5A). Next, we speculated that, as an alternative
mechanism, MuRF1 and MuRF2 might regulate the transla-
tional machinery directly (e.g., via interaction with INT6,
EEF1G, GFM1; see Figure 3). When testing the myocardial
expression of MuRF1/2-associated translation factors, we
found that EEF1G and INT6 (subunits of EF-1 and elF3a,
respectively; see Belle et al, 1995; Morris et al, 2007) were
upregulated speciﬁcally after deletion of all four MuRF1/2
alleles (Figure 6A). Consistent with a general translational
activation, we found upregulation of p70S6K (Figures 6A)
and its activated phosphorylated form phospho-p70S6K, as
well as its substrate phospho-S6 (markers for an activated
Akt/mTor pathway; see Figure 6B). Phospho-p70S6K was
recruited to the nucleus (Figure 6B), thus mimicking changes
observed in exercise-induced translational activation
(Koopman et al, 2006). For SRF, we noted no nuclear recruit-
ment after MuRF1/2 deletions (Figure 6C).
To test more directly for translational activation, we in-
jected deuterium-labeled phenylalanine (D5-F) into dKO and
control mice, allowing the determination of fractional de novo
muscle protein synthesis by comparing D5-F to phenylalanine
contents in muscle protein lysates (see, e.g., Dardevet et al,
2002). Incorporation of D5-F into dKO myocardium after 2
days was 46.6% higher than in WT myocardium (Figure 6D),
whereas incorporation of D5-F into WT, MuRF1-KO, and
MuRF2-KO mice was statistically not different. Consistent
with a chronically elevated rate of muscle metabolism, we
found that serum creatinine levels (a degradation product
of the muscle creatinine) were elevated by 55% in dKO
compared to WT mice (Figure 6E).
Taken together, these data point at the synergistic activa-
tion of the translational machinery in the absence of both
MuRF1 and MuRF2, causing marked upregulation of phos-
pho-S6K (or S6), whose level is tightly correlated with total
muscle protein mass in rodents (Baar et al, 2000).
Discussion
The fulminant cardiac phenotype of dKO mice documents the
synergistic cooperation of the two homologous RING ﬁnger
proteins MuRF1 and MuRF2: inactivation of the four MuRF1/2
alleles leads to 74% early postnatal lethality. Autopsy and
Figure 5 Characterization of altered signaling pathways in dKO
myocardium by western blot studies. (A) Upregulation of the
MuRF1/MuRF2 binding proteins CARP, FHL2, and SQSTM1 in
dKO myocardium. Striking upregulation required the deletion of
all four MuRF1/2 alleles, suggesting that both MuRF1 and MuRF2
synergistically control the transcriptional regulators CARP, FHL2,
and SQSTM1. Below, cTnI and total multi-ubiquitinated protein
species were not affected by the inactivation of MuRF1 and MuRF2
alleles. Among SUMO family members, we noticed for SUMO4
differential reactivity in the 8–30kDa region. (B, C) Hyperactive
stretch signaling in dKO as suggested by chronic upregulation of
stretch-dependent signaling markers. (B) In myocardium, ANP is
barely detectable in WT, MuRF1-KO, and MuRF2-KO hearts. ANP
is strikingly upregulated in dKO myocardium (ventricles, 12 months
old). Other markers for cardiomyopathy/hypertrophy remain nor-
mal or are moderately upregulated: SERCA2a (used as a marker for
heart failure/calcium overload), SRF (previously implicated in
stretch-dependent MuRF2 signaling), p38 Map kinase (a marker
for ERK signaling and heart failure). (C) In dKO quadriceps muscles,
hyperactive stretch signaling was suggested by the effect of 72h
immobilization on the stretch marker MLP: abnormally high levels
of MLP/Crsp3 are maintained after 72h immobilization in dKO
quadriceps (NT¼no treatment, byc¼bycast immobilization).
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of early postnatal death (see Supplementary Figure 2). After
birth, dKO mice develop three- to fourfold enlarged hearts,
whereas mice possessing a single intact MuRF1 or MuRF2
allele are healthy (reminiscent of functional complementation,
e.g., MyoD and Myf5, where only removal of both proteins
leads to a severe phenotype (Rudnicki et al, 1993). Thus, this is
to our knowledge the ﬁrst report showing the convergent
signaling of two ubiquitin ligases (i.e., MuRF1 and MuRF2)
in control of the trophic muscle state, molecules that have
previously been implicated in skeletal muscle wasting and
atrophy (for MuRF1, see Bodine et al, 2001; Lecker et al, 2004;
Nikawa et al, 2004) or in stretch-dependent control of muscle
gene expression (for MuRF2, see Lange et al, 2005).
Intriguingly, those dKO animals surviving the ﬁrst 2 weeks
have a normal life expectancy and are fertile, possibly because
they ‘outgrow’ the initial massive enlargement of their hearts
after birth: chest cavities expand after birth and relative HW/
BW ratios drop from about 231% at 2 weeks of age to 84% at
month 18. Longevity of 26% of the dKO mice also allowed us
to study the functional consequences of MuRF1/2 absence in
ageing skeletal muscle: signiﬁcant quadriceps skeletal muscle
hypertrophy only developed after inactivation of both MuRF1
and MuRF2, and muscle hypertrophy was linked to ﬁber
hypertrophy (Figure 2B).
A likely molecular explanation for MuRF1/2 cooperativity
is their recognition of 35 or more shared targets: our YTH
screens implicated both MuRF1 and MuRF2 in the recogni-
tion of speciﬁc components of the Z-disk, transcriptional
regulators, the translational machinery, and the mitochon-
drial metabolism. Thus, MuRF1/2 recognize a broader range
of targets than detected previously. Based upon a recent study
on the interaction of cMuRF1 with titin A168–170 (Mrosek
et al, 2007), we speculate that the coiled-coil domains of
MuRF1/2 (MuRFcc) have an extended ﬂexible shape enabling
multiple protein/protein interactions, thereby allowing the
MuRF1/2cc domains to function as a recognition domain for
numerous physiological targets. Thereby, MuRF1/MuRF2
could possibly orchestrate Z-disk signaling, transcription,
translation, and mitochondrial and cytoplasmic metabolism
in a coordinated fashion.
Analysis of dKO muscle tissues provided insights into the
molecular mechanisms causing MuRF-dependent muscle hy-
pertrophy that previous studies might have missed, because
MuRF2 might have complemented for MuRF1 and vice versa
in single KO models (Bodine et al, 2001; Willis et al, 2007):
Our studies identiﬁed two causes that are likely to promote
muscle hypertrophy in dKO mice. First, translation is
enhanced in dKO myocardium as demonstrated by the
upregulation of the downstream control check point S6 and
the increased de novo muscle protein synthesis. As a potential
mechanism leading to downstream translational activation,
our YTH studies identiﬁed the interaction of MuRF1/2 with
Figure 6 Elevated muscle protein synthesis after inactivation of
MuRF1 and MuRF2. (A) The translation elongation factor EEF1G
(interacting with MuRF1 and MuRF2; see Figure 3), its binding
protein elF3a subunit INT6, and the translation-promoting p70S6
kinase are upregulated in dKO myocardium. (B) Immuno-
histochemistry with phospho-speciﬁc antibodies demonstrated the
upregulation of the activated forms of p70S6K and its substrate S6
(phospho-p70S6K and phospho-S6, respectively) in dKO myocar-
dium, suggesting activation of the AKT/mTOR pathway. Scale bar,
20mm. (C) Nuclear entry of phospho-p70S6K was stimulated in dKO
myocardium, whereas cellular distribution of SRF did not change
signiﬁcantly (data represent counts of 200 nuclei on 4HPF sections).
(D) Fractional synthesis rate (% per 48h) of total cardiac muscle
proteins was determined by injecting D5-F i.p. into mice of each
genotype (n¼6). Total cardiac muscle protein synthesis is elevated
in dKO myocardium (P¼0.05 in dKO versus WT, mice aged
between 6 and 16 months). (E) Serum level of creatinine was
increased in dKO mice (n¼6 in each group, P¼0.01 in dKO versus
WT mice, mice aged between 6 and 16 months).
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INT6 (recently identiﬁed as a regulator of translation initiation
factor 3; see Morris et al, 2007), EEF1G (a component of the
elongation factor complex EF-1 that is sophisticatedly regu-
lated during development and the cell cycle; see Belle et al,
1995), and GFM1 (the mitochondrial elongation factor G1).
These interactions together with the translational activation
in dKO myocardium suggest that enhanced muscle synthesis
accounts for muscle hypertrophy, whereas reduced protein
degradation by multi-ubiquitination is at least less important.
Consistent with enhanced muscle protein turnover in addition
to a globally reduced muscle protein catabolism, we found
elevated creatinine levels in the sera of dKO mice (Figure 6E).
As a second mechanism explaining muscle hypertrophy in
dKO mice, we found that both cardiac and skeletal dKO
muscles expressed elevated levels of stretch markers, including
ANP and MLP (which again are predicted to promote muscle
protein synthesis). Both ANP and MLP are also components of
the myoﬁbrillar Z-disk. Interestingly, ANP, CARP (both also
highly upregulated in young dKO mice; see Supplementary
Figure 10), and MLP all target to the myoﬁbrillar Z-disk region
(Bang et al,2 0 0 1 ;K n o e l let al, 2002; Hoshijima, 2006).
Consistent with a higher content of Z-disk proteins in dKO
muscles, our EM studies showed denser and widened Z-disks
(Figure 4), a lattice structure that performs stretch-sensing
functions in muscle tissues (Vigoreaux, 1994; Knoell et al,
2002). Finally, failure to downregulate MLP after immobiliza-
t i o ns u g g e s t st h a td K Om u s c l e sc h r o n i c a l l ye x p r e s sh i g hl e v e l s
of MLP independently of muscle exercise (Figure 5C).
Hyperactive anabolic stretch-sensing pathways could also
potentially explain the unexpected lean phenotype of dKO
mice: our adult C57/BL6 laboratory mice with unlimited
access to nutrition and limited physical activity gained
about 4% weight per month by fattening. In contrast, our
dKO mice (back-crossed onto the same genetic background)
failed to accumulate fat (Figure 2C). This could be explained,
at least in part, by the activation of muscle protein synthesis
and metabolism, recruiting a larger fraction of dietary
calories for protein anabolism. Alternatively, MuRF1 and
MuRF2 may also exert direct effects on lipid metabolism, as
enoyl-coenzyme hydratase I (interacting with both MuRF1
and MuRF2; see Figure 3A; for review, see Kim and Battaile,
2002) participates in the b-oxidation of lipids.
Overall, the phenotype of dKO mice together with previous
data (Arya et al, 2004; Kedar et al, 2004; Willis et al, 2007) are
consistent with a role of MuRF1/2 to serve as an inhibitory
feedback loop to downregulate anabolic responses after
stretch/strain and metabolic stress: inactivation of MuRF1
and MuRF2 results in chronically elevated stretch signals,
both in the heart (for ANP, see Figure 5B and Supplementary
Table 10; array data on ArrayExpress accession E-MEXP-1321)
and in skeletal muscle (for MLP, see Figure 5C). Future
molecular insights into the signaling pathways shared by
MuRF1 and MuRF2 may allow the design of combined
MuRF1/MuRF2 inhibitors to achieve the effects seen in dKO
mice including elevated muscle protein synthesis, failure to
accumulate body fat during ageing, and maintenance of
elevated trophic stretch signals. Although such a strategy
will require considering cardiac hypertrophy as an additional
unwanted effect the survival of dKO mice until month 18
encourages strategies to target MuRF1/MuRF2 for stimulating
muscle anabolically. Finally, the striking lipolysis in dKO
mice warrants future studies on the potential role of MuRF1
and MuRF2 in lipid and energy metabolism.
Materials and methods
Inactivation of the murine MuRF1 and MuRF2 genes and
mouse breeding
The murine MuRF1 and MuRF2 genes were targeted by homologous
recombination into exons 2 and 5, respectively (Witt et al, 2001).
Two independent ES cell clones for each targeting were obtained,
homologous integration veriﬁed, and mouse generated essentially
as previously described (Witt et al, 2001). Homologous recombina-
tion caused the complete loss of MuRF1 and MuRF2 transcripts,
respectively, as detected by RT-PCR (see Supplementary Figure 1D).
129/C57/BL6 hybrid mice were back-crossed with C57/BL6 over
generations to obtain a comparable genetic background. During
breeding of 129/C57/BL6 mice, MuRF1 and MuRF2 null alleles
segregated Mendelian. Because of the high lethality, dKO mice were
obtained exclusively by breeding double heterozygous mice to
avoid any selection of potential modiﬁers.
YTH interaction studies
For YTH screens and mating experiments, the human full-length
MuRF1 and MuRF2 fragments were ampliﬁed from total human
skeletal muscle cDNA with the following primer pairs (small letters
denote cloning sites): MuRF1-S, tttccatg-GAGAACTTGGAGAAGCA
GCTGATCTGC, 478S; MuRF1-R, ttttagatct-TCTGGGGGCCTCTCATTC
ATCCAGCTC, 1525R; MuRF2-S, tttagatct-GATAACTTAGAGAAGC
AACTCATCTGTCCC, 184S; MuRF2-R, tttgtcgac-AGAGGGGCAGCAG
TTGGAATGAATATC,1808R.
Sequencing conﬁrmed identity to the data library entries and
AJ291712 and AJ291713. For MuRF2, the isoform ampliﬁed from
total human heart corresponded to the 50kDa version (see
McElhinny et al, 2004). The full-length MuRF1,2 fragments were
inserted into pGBKT7 (Clontech) and the recombinant MuRF1,2
baits were transformed into Saccharomyces cerevisiae, strain AH109.
For screening, AH109 cells were co-transformed with 40mgo f
ampliﬁed human skeletal muscle cDNA and cardiac cDNA libraries,
prepared in pACT2 prey vector (Matchmaker skeletal cDNA library
no. 638818 and cardiac library no. 2020484, Clontech). The YTH
screens were essentially performed as described by the manufac-
turer (Yeastmaker Yeast Transformation System 2, Clontech). Co-
transformed cells were incubated for 5 days at 301C on SD/Leu-/
Trp-/His-plates. Subsequent determination of b-galactosidase acti-
vities, further mapping studies by mating of deletion constructs,
rescue of plasmid DNA from interacting prey clones, and their
sequence analysis with AD3 primer were as described previously
(Witt et al, 2005).
Cine MRI
Cine MRI was performed on a high ﬁeld 7.05 Tesla Biospec magnet
(Bruker, Ettlingen, Germany) using an ECG and respiratory
triggered fast gradient echo FLASH (Haase et al, 1986) sequence
(for imaging parameters, see Ruff et al, 1998; Wiesmann et al, 2000;
ﬂip angle 25–401; echo time 1.7ms; repetition time 7–16ms
(depending on the heart rate and number of frames per heart
cycle); ﬁeld of view 30mm
2; image matrix 128 128; in-plane
resolution 230mm and slice thickness 1.0mm. A total of 12–18
frames per heart cycle and 10–12 contiguous ventricular short-axis
slices were acquired to cover the entire heart. A birdcage probehead
with an inner diameter of 35mm for transmission and reception of
the MR signal and a microimaging system with rapid gradient
performance (maximum gradient strength 870mTm
 1 and 280ms
rise time) were used. The size of myocardial and ventricular
compartments was determined by semi-automated segmentation in
the short-axis slice images covering the entire heart. Endocardial
borders in all end-diastolic and end-systolic frames were delineated,
clearly distinguishable due to the high MRI-derived non-saturated
spin contrast between the blood-ﬁlled ventricular cavity and the
myocardial tissue. The obtained compartment areas were multiplied
with the slice thickness to determine the myocardial and ventricular
slice volumes. Ventricular volumes were calculated as follows:
stroke volume¼SV, end-diastolic volume¼EDV, end-systolic volu-
me¼ESV; EF¼SV/EDV and cardiac output CO¼SV heart rate.
Myocardial masses were calculated from the multiplication of the
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(1.05gcm
 3). Volumes and masses were calculated with similar
reproducibility and accuracy as known from human MR studies and
to autopsy data (Ruff et al, 1998).
Protein expression, antibodies, western blot analysis and
pull-downs
Full-length CARP, MRP-L41/pig3, and an N-terminal fragment of
myozenin-1/calsarcin-2 was cloned into pETM-44 region, and
maltose-binding protein (MBP) fusions were expressed in BL21-
DE3 as described below. For cloning, the following primer pairs
were used to amplify the desired fragments from total cardiac
muscle cDNA: CARP-253S, tttagatct-ATGGTACTGAAAGTAGAGGAA
CTGGTCACT; CARP-1210R, tttgtcgac-TCAGAATGTAGCTATGCGAGA
GGTCTTGTA; myozenin-1/calsarcin2 378S, tttctcgagc-GGAACCCCG
GCCCCTAATAAGAAG; myozenin-1/calsarcin2 830R, tttacgcgtta-TC
CTCCTCTGCCAGCCTGGCC; MRP-L41/pig3-106S, tttcc-ATGGGCGT
CCTGGCCGCAGC; MRP-L41/pig3-519R, tttggatc-CTAGCGCAGGAA
GTTCCTGGGGTAGAG; GFM1-1491S, tttccatg-GATCTGGAAAAATTT
TCAAAAGGTATTGGC; GFM1-2384R, tttggatcc-GTCAACTCACAGTA
AGCAAAGTTAGTTCTTGGCT; EEF1G-140S, ATCACCATGGCGGCT
GGGACCCTGTACACG; EEF1G-1460R, tttggtacc-TCACTTGAAGATCT
TGCCCTGATTGAAGGC.
For protein expression in Escherichia coli,c o n s t r u c t sw e r e
transformed into BL21-DE3, grown in LB supplemented with
kanamycin (20mg/ml) to an OD of 0.6, and T7-driven expression
of insert proteins was induced by the addition of IPTG to a ﬁnal
concentration of 200mM. Harvesting of cells, their lysis, and
puriﬁcation of His-tagged protein complexes on Ni-NTA agarose
was essentially as described by manufacturers for induction of
protein expression (see Novagen, www.emdbiosciences.com/html/
NVG/literature; for His-tag fusion protein puriﬁcation, see Qiagen).
After Ni-NTA puriﬁcation, speciﬁcally bound proteins were eluted
with 300mM imidazole. Pull-down experiments were performed
essentially as described by Mrosek et al (2007). In brief, MuRF1
fragments (see Supplementary Figure 1) or MuRF1/MuRF2 ligands
were cloned into pETM-44 and expressed as MBP fusions. Complexes
of MuRF1/MuRF2 with its ligands were puriﬁed on amylose
agarose (New England Biolabs) essentially as described by the
manufacturer.
Antibodies: CARP speciﬁc antibodies have been described
previously (Miller et al, 2003; Witt et al, 2004). Other antibodies
used:
For western blot analysis, blots of mouse ventricle tissue lysates
were probed with afﬁnity puriﬁed primary antibodies. Muscle tissue
lysates were prepared from snap-frozen mouse ventricles. Brieﬂy,
pulverized heart muscle was solubilized in RIPA buffer (10ml NP-
40, 150mM NaCl, 50mM Tris–HCl, 1mM EDTA, 5ml sodiumdeox-
ycholate, pH¼7.2). Western blot analysis was performed essen-
tially as described previously (Witt et al, 2006).
Expression proﬁling (Affymetrix gene chip analysis) was per-
formed essentially as described previously (Witt et al,2 0 0 4 ) .W e
used the Mouse Genome 430 2.0 array and compared two WT/dKO
pairs from matched litters at 4 months of age. Data were analyzed
with SAS. The raw data have been deposited on ArrayExpress
(http://www.ebi.ac.uk/arrayexpress, accession E-MEXP-1321); se-
lected genes are presented in Supplementary Table 9.
Immunoﬂuorescence and electron microscopy
Immunoﬂuorescence microscopy was performed on muscle strips
dissected from left ventricular walls from 3-month-old WT, dKO,
MuRF1, and MuRF2 KO mice. Cryo-sectioning, immunolabeling,
and electron microscopy were essentially as described previously
(Witt et al, 2006). Images were acquired with a Zeiss AxioPlan2
microscope. For morphometric analysis, the amount of cells per
2mm
2 was analyzed with Zeiss AxioVision LE 4.3 software.
Bycast immobilization of quadriceps muscles was performed
essentially as described by Kemp et al (2000) using 5-month-old
mice and for every genotype in duplicate. Right-sided quadriceps
muscles of KO and matched WT mice were immobilized by a plaster
bycast for 72h. Mice were killed, quadriceps muscles were analyzed
by Affymetrix arrays, and western blots were performed as
described previously. Induction of a subset of genes including
MAFbx/atrogin1 was monitored as a positive control for immobi-
lization in by-casted skeletal muscles.
D5-phenylalanine incorporation
D5-phenylalanine (D5-F) was purchased from Sigma. A total of
50mmol/100g mouse weight (prepared in 0.9% NaCl) was injected i.p.
into mice that were kept for 48h and fed ad libitum. Incorporation of
D5-F into mouse hearts was determined essentially as described
(Dardevet et al, 2002). Brieﬂy, mice were killed 48h after the D5-F
injection, TCA insoluble total muscle proteins were lysed in 6M HCl,
and total amino acids were puriﬁed by passing over cation exchange
column (AG50 W-X8, Bio-Rad). Fractional total muscle protein
synthesis was estimated by determining the Mw 166.1 (Phenylalanine)
and 171.1 (D5-F) ratios in the respective samples.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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